Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology

4 Oct 2023

Abstract excerpt

Aim: Alzheimer's disease causes dementia which impairs the cognitive domains. Methodology: The pharmacokinetic characteristics and biological activity of echinocystic acid are predicted in this work using in silico or computational approaches, including pkCSM, Swiss ADME, OSIRIS® property explorer, PASS online web resource and MOLINSPIRATION® software. Results & discussion: The compound has lipid metabolism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38827791
DOI: 10.2144/fsoa-2023-0150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathologyPMID 38827791Read ↗

African Natural Products for Multitarget-Based Treatment of Alzheimer’s Disease: An In Silico StudySemantic proximity Read ↗

Acetylcholinesterase Inhibitory Potential of Plant-Based Phenolics in the Treatment of Alzheimer's Disease: An In Silico ApproachSemantic proximity Read ↗

Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidenceSemantic proximity Read ↗

A Novel multifunctional 5,6-dimethoxy-indanone-chalcone-carbamate hybrids alleviates cognitive decline in Alzheimer’s disease by dual inhibition of acetylcholinesterase and inflammationSemantic proximity Read ↗

Network Pharmacology and molecular docking approach to unveil the mechanism of <i>Hypericum perforatum</i> in the management of Alzheimer’s disorderSemantic proximity Read ↗

Effect of Terpenes from <i>Poria Cocos</i> : Verifying Modes of Action against Alzheimer’s disease Using Molecular Docking, Drug-induced Transcriptomes and Diffusion NetworkSemantic proximity Read ↗

Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative DiseasesSemantic proximity Read ↗

Ethyl caffeate ameliorated amyloid‐beta42 protein‐associated toxicity in PC12 cells andDrosophila melanogasterSemantic proximity Read ↗

The Protective and Therapeutic Anti-Alzheimer Potential of Olea europaea L. cv. Picual: An In Silico and In Vivo StudySemantic proximity Read ↗

Long-Term Neurotoxic Effects and Alzheimer’s Disease Risk of Early EHDPP Exposure in Zebrafish: Insights from Molecular Mechanisms to Adult PathologySemantic proximity Read ↗

Natural inhibitors of DYRK1A as drug candidates against Alzheimer Disease: QSAR, molecular docking, molecular dynamics simulation and drug evaluation assessmentSemantic proximity Read ↗

The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.